Global Medical Second Opinion Market (2014-2020)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
To Enquire About<br />
the Report Click<br />
Here<br />
IndustryARC<br />
<strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> (<strong>2014</strong>-<strong>2020</strong>)<br />
By Disease (Cancer, Cardiac Disorders, Diabetes, Injuries and Others); By Service<br />
Providers (Hospitals, Online and Offline <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> Providers and Health<br />
Insurance Players) & By Geography
To Enquire About<br />
the Report Click<br />
Here<br />
TABLE OF CONTENTS<br />
1. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Overview<br />
2. Executive Summary<br />
3. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Landscape<br />
3.1. <strong>Market</strong> share Analysis<br />
3.2. Comparative Analysis<br />
3.2.1. Product Benchmarking<br />
3.2.2. End-User Profiling<br />
3.2.3. Patent Analysis<br />
3.2.4. Top 5 Financial Analysis<br />
4. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> - <strong>Market</strong> Forces<br />
4.1. <strong>Market</strong> Drivers<br />
4.2. <strong>Market</strong> Constraints<br />
4.3. <strong>Market</strong> Challenges<br />
4.4. Attractiveness of the Industry<br />
4.4.1. Power of Suppliers<br />
4.4.2. Power of Customers<br />
4.4.3. Threat of New entrants<br />
4.4.4. Threat of Substitution<br />
4.4.5. Degree of Competition<br />
5. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> – Strategic Analysis<br />
5.1. Value Chain Analysis<br />
5.2. Pricing Analysis<br />
5.3. Opportunity Analysis
To Enquire About<br />
the Report Click<br />
Here<br />
5.4. Product Life Cycle Analysis<br />
5.5. Suppliers & Distributors<br />
6. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> – By Disorders<br />
6.1. Introduction<br />
6.2. Cancer<br />
6.3. Diabetes<br />
6.4. Cardiac disorders<br />
6.5. Neurological disorders<br />
6.6. Ocular disorders<br />
6.7. Pulmonary disorders<br />
6.8. Nephrological disorders<br />
6.9. Allergies<br />
6.10. Injuries<br />
6.11. Others<br />
7. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> – By Service Providers<br />
7.1. Introduction<br />
7.2. Hospitals<br />
7.3. <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> Providing Companies<br />
7.4. Health Insurance Companies<br />
7.5. Online Services<br />
7.6. Others<br />
8. <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> – By Geography<br />
8.1. Introduction<br />
8.2. Americas
To Enquire About<br />
the Report Click<br />
Here<br />
8.2.1. U.S.<br />
8.2.2. Canada<br />
8.2.3. Brazil<br />
8.2.4. Argentina<br />
8.2.5. Others<br />
8.2.6. Europe<br />
8.2.7. U.K.<br />
8.2.8. Germany<br />
8.2.9. France<br />
8.2.10. Spain<br />
8.2.11. Italy<br />
8.2.12. Others<br />
8.3. APAC<br />
8.3.1. China<br />
8.3.2. Japan<br />
8.3.3. India<br />
8.3.4. Australia<br />
8.3.5. Others<br />
8.4. RoW<br />
8.4.1. Middle East<br />
8.4.2. Africa<br />
9. <strong>Market</strong> Entropy<br />
9.1. New Product Launches<br />
9.2. M&As, Collaborations, Partnerships & JVs
To Enquire About<br />
the Report Click<br />
Here<br />
10. Investment Opportunities<br />
11. Company Profiles<br />
11.1. Advance <strong>Medical</strong><br />
11.2. Mediguide America<br />
11.3. Johns Hopkins USA<br />
11.4. Best Doctors<br />
11.5. Cleveland Clinic<br />
11.6. Bupa <strong>Global</strong><br />
11.7. WorldCare International Inc.<br />
11.8. Grand Rounds<br />
11.9. XMRI.com<br />
11.10. HCA Hospitals<br />
11.11. Penn Medicine<br />
11.12. Cynergy Care<br />
11.13. MediAngels.com<br />
11.14. <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> Pvt. Ltd.<br />
11.15. UC San Diego Health System<br />
11.16. AXA PPP Healthcare<br />
12. Appendix<br />
12.1. Abbreviations<br />
12.2. Sources<br />
12.3. Research Methodology<br />
12.4. Bibliography<br />
12.5. Compilation of Expert Insights
12.6. Disclaimer<br />
To Enquire About<br />
the Report Click<br />
Here
To Enquire About<br />
the Report Click<br />
Here<br />
LIST OF TABLES<br />
Table 1 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> – Pricing Analysis ($)<br />
Table 2 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 3 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Cancer, By Service Providers, <strong>2014</strong>-<br />
<strong>2020</strong> ($M)<br />
Table 4 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Cancer, By, By Geography, <strong>2014</strong>-<br />
<strong>2020</strong> ($M)<br />
Table 5 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Diabetes, By Service Providers, <strong>2014</strong>-<br />
<strong>2020</strong> ($M)<br />
Table 6 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Diabetes, By, By Geography, <strong>2014</strong>-<br />
<strong>2020</strong> ($M)<br />
Table 7 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Cardiac disorders, By Service<br />
Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 8 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Cardiac disorders, By, By Geography,<br />
<strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 9 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Neurological disorders, By Service<br />
Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 10 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Neurological disorders, By, By<br />
Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 11 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Ocular disorders, By Service<br />
Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 12 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Ocular disorders, By, By Geography,<br />
<strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 13 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Pulmonary disorders, By Service<br />
Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 14 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Pulmonary disorders, By, By<br />
Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 15 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Nephrological disorders, By Service<br />
Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 16 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Nephrological disorders, By, By<br />
Geography, <strong>2014</strong>-<strong>2020</strong> ($M)
To Enquire About<br />
the Report Click<br />
Here<br />
Table 17 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Allergies, By Service Providers,<br />
<strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 18 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Allergies, By, By Geography, <strong>2014</strong>-<br />
<strong>2020</strong> ($M)<br />
Table 19 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Injuries, By Service Providers, <strong>2014</strong>-<br />
<strong>2020</strong> ($M)<br />
Table 20 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Injuries, By, By Geography, <strong>2014</strong>-<br />
<strong>2020</strong> ($M)<br />
Table 21 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Other disorders, By Service<br />
Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 22 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue for Other disorders, By, By Geography,<br />
<strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 23 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Service Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 24 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Hospitals, By Disease, <strong>2014</strong>-<strong>2020</strong><br />
($M)<br />
Table 25 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Hospitals, By, By Geography,<br />
<strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 26 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong><br />
Providing Companies, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 27 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong><br />
Providing Companies, By, By Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 28 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Health Insurance Companies, By<br />
Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 29 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Health Insurance Companies, By,<br />
By Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 30 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Online Services, By Disease, <strong>2014</strong>-<br />
<strong>2020</strong> ($M)<br />
Table 31 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Online Services, By Geography,<br />
<strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 32 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Other Service Providers, By<br />
Disease, <strong>2014</strong>-<strong>2020</strong> ($M)
To Enquire About<br />
the Report Click<br />
Here<br />
Table 33 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue from Other Service Providers, By<br />
Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 34 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Geography, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 35 Americas: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Country, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 36 Americas: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 37 Americas: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Service Providers, <strong>2014</strong>-<strong>2020</strong><br />
($M)<br />
Table 38 Europe: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Country, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 39 Europe: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 40 Europe: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Service Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 41 APAC: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Country, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 42 APAC: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 43 APAC: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Service Providers, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 44 RoW: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Country, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 45 RoW: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Disease, <strong>2014</strong>-<strong>2020</strong> ($M)<br />
Table 46 RoW: <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Revenue, By Service Providers, <strong>2014</strong>-<strong>2020</strong> ($M)
To Enquire About<br />
the Report Click<br />
Here<br />
LIST OF FIGURES<br />
Figure1 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong>, By Geography, <strong>2014</strong> - <strong>2020</strong> ($M)<br />
Figure2 Segmentation of <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong><br />
Figure3 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Competitive Share Analysis, <strong>2014</strong>(%)<br />
Figure4 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Disease, <strong>2014</strong> (%)<br />
Figure5 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Service Providers, <strong>2014</strong> (%)<br />
Figure6 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Geography, <strong>2014</strong> (%)<br />
Figure7 Americas <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Country, <strong>2014</strong> (%)<br />
Figure8 Europe <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Country, <strong>2014</strong> (%)<br />
Figure9 APAC <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Country, <strong>2014</strong> (%)<br />
Figure10 RoW <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Share, By Country, <strong>2014</strong> (%)<br />
Figure11 <strong>Global</strong> <strong>Medical</strong> <strong>Second</strong> <strong>Opinion</strong> <strong>Market</strong> Recent Developments, By Year, 2012-2015
To Enquire About<br />
the Report Click<br />
Here<br />
1. GLOBAL MEDICAL SECOND OPINION MARKET<br />
OVERVIEW<br />
1.1 REPORT SCOPE<br />
The global market for medical second opinion has been segmented by the types of disorders, and<br />
the service providers. The major diseases or conditions the patient seeks medical second opinion are<br />
cancer, diabetes, heart and disorders, diseases pertaining to kidneys and liver, allergies and injuries<br />
resulting from accidents and so on. <strong>Medical</strong> second opinion services are mainly provided by<br />
hospitals, private medical second opinion providing companies, health insurance companies and<br />
online service providers. Each of these segmentations has been studied to give a comprehensive<br />
analysis of the global medical second opinion market.<br />
The overall market has also been presented from the perspective of different geographic locations<br />
into standard geographic regions and key economies for this market. Competitive landscape for each<br />
of the capture technologies and storage methods is highlighted and the market players are profiled<br />
with attributes of company overview, financial overview, business strategies, product portfolio and<br />
recent developments. <strong>Market</strong> shares of the key players for <strong>2014</strong> are provided. The prominent players<br />
profiled in this report are Advance <strong>Medical</strong>, Johns Hopkins USA, Cleveland Clinic, WorldCare<br />
International Inc., AXA PPP Healthcare and others.<br />
The report contains the most detailed and in-depth segmentation and analysis of the global medical<br />
second opinion market during the period <strong>2014</strong> - <strong>2020</strong>.<br />
1.2 STAKEHOLDERS<br />
The following are the prominent stakeholders in the global medical second opinion market.<br />
Hospitals and clinics<br />
Doctors and Healthcare professionals<br />
Ministry of health<br />
Patients<br />
Health insurance players<br />
Laboratories and Diagnostic centres<br />
Online and offline medical second opinion service providers<br />
<strong>Medical</strong> colleges and universities<br />
Regulatory and Legislative bodies
To Enquire About<br />
the Report Click<br />
Here<br />
2. EXECUTIVE SUMMARY<br />
<strong>Medical</strong> second opinion refers to a patient’s act of requesting or seeking evaluation of his health<br />
condition by another physician or specialist to verify and confirm the diagnosis and treatment<br />
prescribed by the previous physician or to know an alternative treatment plan. It is primarily sought<br />
after when the first physician recommends a complex/painful surgery or painful and risky<br />
procedures. The other situations that propel the patient to seek a medical second opinion are when<br />
the patients is not sure of the diagnosis or is unsatisfied with the treatment plans offered by the<br />
primary physician or when it is required by the insurance plan or when the physician himself<br />
recommends to go for it.<br />
The overall global medical second opinion market is currently doing well and is on the rise, which is<br />
estimated to rise to $X billion by <strong>2020</strong>, growing at a CAGR of XX%.<br />
SAMPLE TABLE: GLOBAL MEDICAL SECOND OPINION MARKET, BY REGION,<br />
<strong>2014</strong>-<strong>2020</strong> ($M)<br />
Region <strong>2014</strong> 2015 2016 2017 2018 2019 <strong>2020</strong> CAGR%<br />
(2015-<br />
<strong>2020</strong>)<br />
Americas xx xx xx xx xx xx xx xx%<br />
Europe xx xx xx xx xx xx xx xx%<br />
APAC xx xx xx xx xx xx xx xx%<br />
RoW xx xx xx xx xx xx xx xx%<br />
Total xx xx xx xx xx xx xx xx%<br />
Source: IndustryARC Analysis, Expert Insights<br />
The global market for <strong>Medical</strong> second opinions in <strong>2014</strong> is spread throughout the Americas, Europe,<br />
Asia-Pacific and Rest of the world. Americas occupy the largest market share of xx% in <strong>2014</strong>. The<br />
global market is emerging at a steady pace with increase in the number of patients who are willing to<br />
take health insurance and seeking second opinions for better or alternative treatment or diagnosis.<br />
There have been laws emerging in the favor of patients in the U.S. such as Patient Protection and<br />
Affordable Care Act (PPACA) to enhance the quality and affordability of health insurance reforms<br />
and decrease the costs of healthcare services for individuals. The advances in telemedicine or<br />
mHealth help to close the gaps in healthcare by enabling the doctors to attend patient demands in a<br />
short span of time and eliminate the delays in treatment. The individuals are referring to the internet<br />
and mobile applications for second opinion before undergoing complex procedures, thereby<br />
opening a window of opportunity for medical second opinion services.
To Enquire About<br />
the Report Click<br />
Here<br />
SAMPLE FIGURE: GLOBAL ESTIMATED SHARE OF mHEALTH USERS IN<br />
SMARTPHONES, 2050 (%)<br />
mHEALTH<br />
Source: research2guidance<br />
mHealth refers to the seeking of medical help and information from mobile devices such as smart<br />
phones and tablets through internet and specially developed healthcare mobile applications offered<br />
online. In a survey conducted in U.S., it was discovered that more than 50% of the smartphone<br />
users in the U.S. research from their phone for a second opinion before undergoing treatment for<br />
their respective medical condition. This trend has been growing over the years, owing to the<br />
increasing number of smartphones sold. The soaring number of healthcare apps contributes to this<br />
as well. It is estimated that in 2015, there will be a total of 1,400 million smartphone users all over<br />
the world out of which approximately 500 million users make use of healthcare apps, which enables<br />
the mHealth industry to grow.
To Enquire About<br />
the Report Click<br />
Here<br />
KEY MARKET INSIGHTS<br />
• <strong>Medical</strong> second opinion services provided online are gaining importance and the mHealth<br />
technology is growing at a rapid pace due to advances in technology, enabling the patients to<br />
obtain second opinions without much time lapse.<br />
• According to data collected and published in January, 2015 from MediAngels, almost 44% of the<br />
patients who have been prescribed to undergo a surgery avoided it by seeking a medical second<br />
opinion in India.<br />
• A rising trend has been observed in the medical insurance reforms where the healthcare<br />
insurance companies themselves are propelling their clients to for a medical second opinion in<br />
order to save costs for any treatment or surgery which might not be necessary in the first place.
To Enquire About<br />
the Report Click<br />
Here<br />
12.3 RESEARCH METHODOLOGY<br />
The quantitative and qualitative data collected for the global medical second opinion market<br />
report is from a combination of secondary and primary sources. Research interviews were<br />
conducted with executives and/or mangers in the key product manufacturers and related<br />
organizations. These Key <strong>Opinion</strong> Leaders (KOLs) were then provided a questionnaire to gather<br />
quantitative and qualitative inputs on their operations, performance, strategies and views on the<br />
overall market, including key developments and trends. Data from interviews is consolidated,<br />
checked for consistency and accuracy, and the final market numbers are again validated by<br />
experts. The global medical second opinion market was split by diseases, service providers and<br />
geography based on different factors like primary and secondary sources, understanding of the<br />
number of companies operating in each segment and also KOL insights.<br />
We have used various secondary sources such as directories, articles, white papers, newsletters,<br />
annual reports and paid databases such as OneSource, Hoovers and Factiva to identify and<br />
collect information for extensive commercial study of the global medical second opinion market.<br />
The approach towards finding information regarding the market and forecasting has been quite<br />
extensive. The key players in the market and its value chain were identified through secondary<br />
research and their market opinions were also gathered in a similar way through telephonic<br />
interviews and questionnaires. Interviews with key opinion leaders such as managers and<br />
marketing personnel were used extensively in understanding the need and emergence of medical<br />
second opinion market.<br />
We also have extensive database of contacts which were used to conduct primary interviews and<br />
also to get their inputs using questionnaires.
To Enquire About<br />
the Report Click<br />
Here<br />
THE ARC ADVANTAGE<br />
An analytical model lies at the core of our process, ensuring logical consistency throughout<br />
our research. We complement the model with secondary data and interviews with industry<br />
experts to reflect the latest trends. With our final expert validation, we provide you with<br />
only the most accurate and actionable intelligence.<br />
THE ARC PROCESS<br />
Analytical<br />
Method<br />
Base Method<br />
Consolidation<br />
Method<br />
Delphi<br />
Verification<br />
1. Granular<br />
breakdown of<br />
drivers into<br />
factors<br />
2. Validate all<br />
factors in terms<br />
of their present<br />
impact on the<br />
market<br />
3. Assign weights<br />
to these factors in<br />
terms of their<br />
relevance and<br />
impact on the<br />
market<br />
1. Get a topdown<br />
estimate of<br />
the market<br />
2. Follow it up<br />
with a bottom-up<br />
estimate of the<br />
market<br />
3. Check<br />
forconsistency<br />
and new growth<br />
factors that are<br />
relevant over the<br />
next 10 Years<br />
1. Granular<br />
breakdown of<br />
drivers into<br />
factors<br />
2. Validate all<br />
factors in terms<br />
of their present<br />
impact on the<br />
market.<br />
3. Assign weights<br />
to these factors in<br />
terms of their<br />
relevance and<br />
impact on the<br />
market.<br />
1. Verify the<br />
findings of the<br />
model with<br />
experts from<br />
across the value<br />
chain<br />
2. Verify the<br />
findings with<br />
players across<br />
small and large<br />
enterprises<br />
3. Tweak the<br />
model and add<br />
new factors<br />
4. Build the<br />
Analytical Model<br />
4. Build the Base<br />
model<br />
4. Build the<br />
Consolidated<br />
Model<br />
4. Finalize the<br />
ARC Model<br />
ANALYTICAL MODEL BASE MODEL CONSOLIDATED MODEL ARC MODEL
To Enquire About<br />
the Report Click<br />
Here<br />
ABOUT US<br />
IndustryARC was started by a group of young, passionate professionals along with extensively<br />
experienced industry veterans across various business segments. Our focus and expertise is<br />
mainly in the field of analytics, market research and consulting. Our singular goal is to provide<br />
accurate and affordable research to our clients.<br />
Our research team has expertise in diverse fields like Automotive, Chemicals,Consumer<br />
Product & Services, Electronics, Food & Beverages, Healthcare etc., However diverse the<br />
expertise maybe, everyone in our team shares one common trait - we love data and we love<br />
providing solutions to clients using that data even more! Seeing your business flourish based<br />
on our solutions and strategy is what we love the most!<br />
IndustryARC publishes more than 30 reports on an annual basis in the mentioned Industries.<br />
Our reports are in-depth and high quality reports that can help decision makers frame better<br />
strategies for their business requirements. These reports can be further customized as per your<br />
needs.<br />
Disclaimer:<br />
• The reports sold by IndustryARC are limited publications containing valuable market<br />
information provided to a select group of customers in response to orders.<br />
• Our customers acknowledge and agree that any report bought from IndustryARC is for<br />
their own internal use and not for general publication or disclosure to third parties.<br />
• Our reports or part of the reports, information contained in the report, cannot be<br />
shared or resold to any other third party.<br />
• Disclosure to third parties, usage of data in a public document, article or blog by the<br />
customer can be done with prior permission taken from IndustryARC.<br />
For information regarding permissions and sales, contact:<br />
sales@industryarc.com | sanjay.matthews@industryarc.com
To Enquire About<br />
the Report Click<br />
Here<br />
IndustryARC<br />
+1 614 - 588 - 8538<br />
sales@industryarc.com<br />
Copyright ©2015 IndustryARC<br />
All Rights Reserved. This document contains highly confidential information and is the sole<br />
property of IndustryARC. No part of it may be circulated, copied, quoted, or otherwise reproduced<br />
without the approval of IndustryARC.